Shopping Cart
- Remove All
- Your shopping cart is currently empty
Physachenolide C, a selective BET inhibitor, induces apoptosis and arrests the cell cycle at the G0-G1 phase, exhibiting antitumor activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 8-10 weeks | |
50 mg | $1,980 | 8-10 weeks | |
100 mg | $2,500 | 8-10 weeks |
Description | Physachenolide C, a selective BET inhibitor, induces apoptosis and arrests the cell cycle at the G0-G1 phase, exhibiting antitumor activity [1]. |
In vitro | Physachenolide C, at concentrations ranging from 0.01-10 μM over a 48-hour period, impedes the proliferation of Yale University Mouse Melanoma (YUMM) cell lines YUMM2.1 and YUMMER1.7, exhibiting half-maximal inhibitory concentration (IC50) values of 0.5159 μM and 1.8230 μM, respectively. Concurrently, this compound markedly elevates the population of early-stage apoptotic cells and induces cell cycle arrest at the G0-G1 phase [1]. |
In vivo | Physachenolide C, administered intratumorally at a dose of 20 mg/kg daily for 15 consecutive doses, markedly suppressed tumor growth and induced complete regression of tumors in a murine melanoma model, without notable toxicity in the mice. Furthermore, treatment with Physachenolide C resulted in a significant elevation in the proportion of TUNEL-positive cells, reaching 40%, indicating enhanced apoptotic activity [1]. |
Molecular Weight | 544.63 |
Formula | C30H40O9 |
Cas No. | 791117-61-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.